一般內科、慢性BC型肝炎追蹤治療、肝癌局部性治療 (射頻燒灼術)、腹部超音波、消化道內視鏡。
臺北醫學大學醫學系 醫學士、
臺灣大學公衛學院流行病學與預防醫學研究所 碩士
臺灣大學公衛學院流行病學與預防醫學研究所 博士
臺灣大學公衛學院流行病學與預防醫學研究所 碩士
臺灣大學公衛學院流行病學與預防醫學研究所 博士
臺大醫院癌醫中心分院綜合內科部肝膽腸胃科 主治醫師
臺大醫院內科部肝膽腸胃科 主治醫師
日本東京順天堂醫院 研習 (射頻燒灼術)
臺大醫院新竹分院內科部肝膽腸胃科 主治醫師
日本京都大學附設醫院 研習 (進階內視鏡)
臺大醫院內科部肝膽腸胃科 總醫師
臺大醫院內科部 住院醫師 臺大醫院 實習醫師
臺大醫院內科部肝膽腸胃科 主治醫師
日本東京順天堂醫院 研習 (射頻燒灼術)
臺大醫院新竹分院內科部肝膽腸胃科 主治醫師
日本京都大學附設醫院 研習 (進階內視鏡)
臺大醫院內科部肝膽腸胃科 總醫師
臺大醫院內科部 住院醫師 臺大醫院 實習醫師
中華民國醫用超音波學會
台灣肝癌醫學會
台灣腫瘤消融醫學會
台灣消化系內視鏡醫學會
台灣消化系醫學會
台灣內科醫學會
台灣肝癌醫學會
台灣腫瘤消融醫學會
台灣消化系內視鏡醫學會
台灣消化系醫學會
台灣內科醫學會
2023 台灣消化醫學年會優秀壁報獎
2023 亞太肝臟醫學年會(APASL)年輕研究學者最佳壁報獎
2021 台灣消化醫學週(TDDW)年輕研究學者獎
2021 財團法人宋瑞樓教授學術基金會優秀論文獎
2019 台灣肝臟研究學會優秀論文獎
2018 日本消化醫學年會(JDDW)Travel Award
2023 亞太肝臟醫學年會(APASL)年輕研究學者最佳壁報獎
2021 台灣消化醫學週(TDDW)年輕研究學者獎
2021 財團法人宋瑞樓教授學術基金會優秀論文獎
2019 台灣肝臟研究學會優秀論文獎
2018 日本消化醫學年會(JDDW)Travel Award
(1) Pre-operative gamma-glutamyl transferase levels predict outcomes in hepatitis B-related hepatocellular carcinoma after curative resection
Tung-Hung Su, Shang-Chin Huang, Chi-Ling Chen, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang,Yao-Ming Wu, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
J Formos Med Assoc. 2023 May Accepted
(2) Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria
Chian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Liver Cancer (2023): 1-11.
(3) Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity
Sih-Han Liao, Wei-Jung Chang, Chen-Yang Hsu, Amy Ming-Fang Yen, Ting-Yu Lin, Sam Li-Sheng Chen, Tony Hsiu-Hsi Chen
Vaccine. 2022 Oct 17;40(47):6864-6872. doi: 10.1016/j.vaccine.2022.10.011.
(4) Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis
SH Liao, CC Hung, CN Chen, JY Yen, CY Hsu, Amy MF Yen, CL Chen
J Formos Med Assoc. 2021 Jun;120 Suppl 1:S77-S85. doi: 10.1016/j.jfma.2021.04.026. Epub 2021 May 4.
(5) Effectiveness of non-pharmaceutical interventions and vaccine for containing the spread of COVID-19: Three illustrations before and after vaccination periods
TY Lin, SH Liao, CC Lai, E Paci, SY Chuang
J Formos Med Assoc. 2021 Jun;120 Suppl 1:S46-S56. doi: 10.1016/j.jfma.2021.05.015. Epub 2021 May 25.
(6) Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan
SH Liao, CL Chen, CY Hsu, KL Chien, JH Kao, PJ Chen, Tony HH Chen, CH Chen
J Hepatol. 2021 Jul;75(1):132-141. doi: 10.1016/j.jhep.2021.02.029. Epub 2021 Mar 6.
(7) Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma
SC Huang, SH Liao, TH Su, YM Jeng, JH Kao
Hepatol Int. 2021 Feb 5. doi: 10.1007/s12072-021-10146-1. Online ahead of print.
(8) A woman from Vietnam complained of chronic diarrhea: A case report and literature review
SY Wang, SH Liao
AIDM. 09 October 2020. https://doi.org/10.1002/aid2.13249
(9) Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts
HH Lin, SH Liao, YL Huang, KL Liu, JH Kao
J Gastroenterol Hepatol. 2020 Jan;35(1):11. doi: 10.1111/jgh.14821. Epub 2019 Nov 11.
(10) NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
Su TH, Liao SH, Hong CM, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen PJ, Chen DS, Chen CL, Adhoute X, Bourlière M, Kao JH
J Gastroenterol Hepatol. 2019 Dec;34(12):2179-2186. doi: 10.1111/jgh.14705. Epub 2019 Jun 18.
(11) Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma
Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH.
Hepatology. 2019 Jan;69(1):209-221. doi: 10.1002/hep.30162.
(12) An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review
Liao SH, Chen YK, Yu SC, Wu MS, Wang HP, Tseng PH.
SAGE Open Med Case Rep. 2017 May 26;5:2050313X17709190. doi: 10.1177/2050313X17709190. eCollection 2017.
(13) Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy
Lin KY, Liao SH, Liu WC, Cheng A, Lin SW, Chang SY, Tsai MS, Kuo CH, Wu MR, Wang HP, Hung CC, Chang SC.
PLoS One. 2015 Sep 11;10(9):e0137660. doi: 10.1371/journal.pone. 0137660. eCollection 2015.
Tung-Hung Su, Shang-Chin Huang, Chi-Ling Chen, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Tai-Chung Tseng, Chen-Hua Liu, Hung-Chih Yang,Yao-Ming Wu, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
J Formos Med Assoc. 2023 May Accepted
(2) Optimizing Survival Benefit by Surgical Resection by the Seven-Eleven Criteria in Barcelona Clinic Liver Cancer Stage A/B Hepatocellular Carcinoma beyond the Milan Criteria
Chian-Tzu Huang, Yu-Long Chu, Tung-Hung Su, Shang-Chin Huang, Tai-Chung Tseng, Shih-Jer Hsu, Sih-Han Liao, Chun-Ming Hong, Chen-Hua Liu, Hung-Chih Yang, Chun-Jen Liu, Pei-Jer Chen, Jia-Horng Kao
Liver Cancer (2023): 1-11.
(3) Evaluating correlates of protection for mix-match vaccine against COVID-19 VOCs with potential of evading immunity
Sih-Han Liao, Wei-Jung Chang, Chen-Yang Hsu, Amy Ming-Fang Yen, Ting-Yu Lin, Sam Li-Sheng Chen, Tony Hsiu-Hsi Chen
Vaccine. 2022 Oct 17;40(47):6864-6872. doi: 10.1016/j.vaccine.2022.10.011.
(4) Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis
SH Liao, CC Hung, CN Chen, JY Yen, CY Hsu, Amy MF Yen, CL Chen
J Formos Med Assoc. 2021 Jun;120 Suppl 1:S77-S85. doi: 10.1016/j.jfma.2021.04.026. Epub 2021 May 4.
(5) Effectiveness of non-pharmaceutical interventions and vaccine for containing the spread of COVID-19: Three illustrations before and after vaccination periods
TY Lin, SH Liao, CC Lai, E Paci, SY Chuang
J Formos Med Assoc. 2021 Jun;120 Suppl 1:S46-S56. doi: 10.1016/j.jfma.2021.05.015. Epub 2021 May 25.
(6) Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan
SH Liao, CL Chen, CY Hsu, KL Chien, JH Kao, PJ Chen, Tony HH Chen, CH Chen
J Hepatol. 2021 Jul;75(1):132-141. doi: 10.1016/j.jhep.2021.02.029. Epub 2021 Mar 6.
(7) Clinical manifestations and outcomes of patients with scirrhous hepatocellular carcinoma
SC Huang, SH Liao, TH Su, YM Jeng, JH Kao
Hepatol Int. 2021 Feb 5. doi: 10.1007/s12072-021-10146-1. Online ahead of print.
(8) A woman from Vietnam complained of chronic diarrhea: A case report and literature review
SY Wang, SH Liao
AIDM. 09 October 2020. https://doi.org/10.1002/aid2.13249
(9) Hepatobiliary and Pancreatic: Biliary hamartoma manifests as liver cysts
HH Lin, SH Liao, YL Huang, KL Liu, JH Kao
J Gastroenterol Hepatol. 2020 Jan;35(1):11. doi: 10.1111/jgh.14821. Epub 2019 Nov 11.
(10) NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
Su TH, Liao SH, Hong CM, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen PJ, Chen DS, Chen CL, Adhoute X, Bourlière M, Kao JH
J Gastroenterol Hepatol. 2019 Dec;34(12):2179-2186. doi: 10.1111/jgh.14705. Epub 2019 Jun 18.
(11) Clinical Manifestations and Outcomes of Patients with Sarcomatoid Hepatocellular Carcinoma
Liao SH, Su TH, Jeng YM, Liang PC, Chen DS, Chen CH, Kao JH.
Hepatology. 2019 Jan;69(1):209-221. doi: 10.1002/hep.30162.
(12) An unusual case of primary hepatic lymphoma with dramatic but unsustained response to bendamustine plus rituximab and literature review
Liao SH, Chen YK, Yu SC, Wu MS, Wang HP, Tseng PH.
SAGE Open Med Case Rep. 2017 May 26;5:2050313X17709190. doi: 10.1177/2050313X17709190. eCollection 2017.
(13) Cholelithiasis and Nephrolithiasis in HIV-Positive Patients in the Era of Combination Antiretroviral Therapy
Lin KY, Liao SH, Liu WC, Cheng A, Lin SW, Chang SY, Tsai MS, Kuo CH, Wu MR, Wang HP, Hung CC, Chang SC.
PLoS One. 2015 Sep 11;10(9):e0137660. doi: 10.1371/journal.pone. 0137660. eCollection 2015.
(1) 貝氏統計模型應用於評估及預測肝癌發生率、致死率與死亡率
研究生:廖思涵 指導教授:陳秀熙／簡國龍(碩士論文)
(2) 病毒性肝癌精準預防
研究生:廖思涵 指導教授:陳秀熙／簡國龍(博士論文)
研究生:廖思涵 指導教授:陳秀熙／簡國龍(碩士論文)
(2) 病毒性肝癌精準預防
研究生:廖思涵 指導教授:陳秀熙／簡國龍(博士論文)